论文部分内容阅读
目的:分析急性创伤性休克患者应用C-反应蛋白以及前白蛋白进行预后评估的临床情况。方法:随机选择深圳市龙华新区中心医院2014年1月至2015年12月急诊科收治的急性创伤性休克患者54例。按照预后结果将他们划分成非死亡组38例和死亡组16例,对两组患者治疗期间的C-反应蛋白以及前白蛋白指标情况进行统计学分析和对比。结果:临床比较统计,两组患者第1天的指标水平比较,差异无统计学意义(P>0.05)。之后治疗中非死亡组患者的C-反应蛋白指标明显低于死亡组患者,前白蛋白指标明显高于死亡组患者,两组对比,差异具有统计学意义(P<0.05)。结论:C-反应蛋白和前白蛋白指标能够有效反映和评估急性创伤性休克患者的临床预后情况,以便医护人员及时调整临床治疗方案。
PURPOSE: To analyze the clinical outcome of patients with acute traumatic shock using C-reactive protein and prealbumin for prognostic assessment. Methods: A total of 54 patients with acute traumatic shock admitted to Emergency Department of Longhua New District Central Hospital from January 2014 to December 2015 were selected. According to the prognosis, they were divided into 38 cases of non-death group and 16 cases of death group. The C-reactive protein and pre-albumin index of two groups were statistically analyzed and compared. Results: Clinical statistics, the two groups of patients on the 1st day of the index levels, the difference was not statistically significant (P> 0.05). After treatment, the C-reactive protein level in the non-death group was significantly lower than that in the death group, and the prealbumin index was significantly higher than the death group. There was significant difference between the two groups (P <0.05). Conclusion: C-reactive protein and prealbumin indicators can effectively reflect and assess the clinical prognosis of patients with acute traumatic shock so that medical staff can timely adjust the clinical treatment plan.